Biomarkers for antimicrobial stewardship: a reappraisal in COVID-19 times?

por van Berkel, Miranda, Kox, Matthijs, Frenzel, Tim, Pickkers, Peter, Schouten, Jeroen
Publicado 2020

Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients

por Kooistra, Emma J., van Berkel, Miranda, van Kempen, Noortje F., van Latum, Celine R. M., Bruse, Niklas, Frenzel, Tim, van den Berg, Maarten J. W., Schouten, Jeroen A., Kox, Matthijs, Pickkers, Peter
Publicado 2021